These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18251066)

  • 1. Biomarkers provide clues to earlier diagnoses. Tiny molecules in the bloodstream may help doctors identify heart disease sooner, which could lead to more timely treatments.
    Heart Advis; 2007 Sep; 10(9):7. PubMed ID: 18251066
    [No Abstract]   [Full Text] [Related]  

  • 2. Tests that predict your cardiac future. Several tests assess risk of coronary heart disease, heart attack and death from heart disease, but can better prediction lead to successful prevention?
    Heart Advis; 2007 Jul; 10(7):3. PubMed ID: 17695653
    [No Abstract]   [Full Text] [Related]  

  • 3. B-type natriuretic peptide (BNP) or N-terminal-proBNP for the diagnosis of heart failure: which peptide is the better choice?
    Kragelund C; Omland T
    Scand J Clin Lab Invest; 2005; 65(8):629-32. PubMed ID: 16319037
    [No Abstract]   [Full Text] [Related]  

  • 4. Perioperative B-type Natriuretic Peptide/N-terminal pro-B-type Natriuretic Peptide: Next Steps to Clinical Practice.
    Fox AA
    Anesthesiology; 2015 Aug; 123(2):246-8. PubMed ID: 26049555
    [No Abstract]   [Full Text] [Related]  

  • 5. Natriuretic peptides find a new home in pulmonology.
    Socrates T; Müller C
    Respiration; 2009; 77(4):368-9. PubMed ID: 19346742
    [No Abstract]   [Full Text] [Related]  

  • 6. Research digest: cardiac biomarkers for risk prediction.
    Preiss D; Sattar N
    Lancet Diabetes Endocrinol; 2016 Nov; 4(11):890. PubMed ID: 27743976
    [No Abstract]   [Full Text] [Related]  

  • 7. Limitations of N-Terminal Pro-B-Type Natriuretic Peptide in the Diagnosis of Heart Disease among Cancer Patients Who Present with Cardiac or Pulmonary Symptoms.
    Wieshammer S; Dreyhaupt J; Müller D; Momm F; Jakob A
    Oncology; 2016; 90(3):143-50. PubMed ID: 26871423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal pro-brain natriuretic peptide predicts the clinical outcome following valve replacement surgery.
    Ren B; Wu H; Yin R; Shi Z; Zhu J; Jing H
    Clin Chim Acta; 2006 Dec; 374(1-2):149-50. PubMed ID: 16836990
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma pro-brain natriuretic peptide and electrocardiographic changes in combination improve risk prediction in persons without known heart disease.
    Jørgensen PG; Jensen JS; Appleyard M; Jensen GB; Mogelvang R
    Int J Cardiol; 2015 Dec; 201():104-9. PubMed ID: 26292277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Echocardiography and N-terminal pro BNP.
    Gundogdu F; Borekci B
    J Perinat Med; 2006; 34(3):253. PubMed ID: 16602851
    [No Abstract]   [Full Text] [Related]  

  • 11. Increase in N-terminal pro-brain natriuretic peptide levels, renal function and cardiac disease in the oldest old.
    Poortvliet R; de Craen A; Gussekloo J; de Ruijter W
    Age Ageing; 2015 Sep; 44(5):841-7. PubMed ID: 26209786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac biomarkers in the critically ill.
    Ventetuolo CE; Levy MM
    Crit Care Clin; 2011 Apr; 27(2):327-43. PubMed ID: 21440204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of high-sensitivity cardiac troponin T in patients receiving anthracycline chemotherapy.
    Blaes AH; Rehman A; Vock DM; Luo X; Menge M; Yee D; Missov E; Duprez D
    Vasc Health Risk Manag; 2015; 11():591-4. PubMed ID: 26648730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-type natriuretic peptide: a universal cardiac biomarker?
    Teodorovich N; Krakover R; Vered Z
    Isr Med Assoc J; 2008 Feb; 10(2):152-3. PubMed ID: 18432033
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of NT-proBNP assay in the management of canine patients with heart disease.
    Oyama MA; Singletary GE
    Vet Clin North Am Small Anim Pract; 2010 Jul; 40(4):545-58. PubMed ID: 20610010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of cardiac biomarkers in neonatology.
    Vijlbrief DC; Benders MJ; Kemperman H; van Bel F; de Vries WB
    Pediatr Res; 2012 Oct; 72(4):337-43. PubMed ID: 22797141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinician's experience of using the Cardiac Reader NT-proBNP point-of-care assay in a clinical setting.
    Alehagen U; Janzon M
    Eur J Heart Fail; 2008 Mar; 10(3):260-6. PubMed ID: 18304871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clearing a path for new cardiac markers.
    Parham S
    CAP Today; 2005 Feb; 19(2):1, 48, 50 passim. PubMed ID: 15787104
    [No Abstract]   [Full Text] [Related]  

  • 19. [Value of N-terminal pro-brain natriuretic peptide in the early evaluation of cardiovasculardysfunction in critically ill children].
    Chen Y; Yu Y
    Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):149-52. PubMed ID: 24739730
    [No Abstract]   [Full Text] [Related]  

  • 20. Questions about ambulatory electrocardiography in Boxers.
    Lugten P
    J Am Vet Med Assoc; 2010 Apr; 236(7):730; author reply 730. PubMed ID: 20401965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.